Anti-BMI1 aptamer SELEX Service(Cat#: CTApt-1758)

This is an aptamer development services to screening aptamers binds to the BMI1 with an affinity of 1nM~1μM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target BMI1
Alternative Names BMI1 Proto-Oncogene, Polycomb Ring Finger; RNF51; Polycomb Group RING Finger Protein 4; Polycomb Complex Protein BMI-1; PCGF4; B Lymphoma Mo-MLV Insertion Region 1 Homolog (Mouse) ; Murine Leukemia Viral (Bmi-1) Oncogene Homolo; B Lymphoma Mo-MLV Insertion Region 1 Homolog; BMI1 Polycomb Ring Finger Proto-Oncogene; BMI1 Polycomb Ring Finger Oncogene; Polycomb Group Ring Finger 4; Polycomb Group Protein Bmi1; Ring Finger Protein 51; RING Finger Protein 51; Flvi-2/Bmi-; FLVI2/BMI1; BMI1
Gene ID 648
UniProt ID P35226
Target Overview This gene encodes a ring finger protein that is major component of the polycomb group complex 1 (PRC1). This complex functions through chromatin remodeling as an essential epigenetic repressor of multiple regulatory genes involved in embryonic development and self-renewal in somatic stem cells. This protein also plays a central role in DNA damage repair. This gene is an oncogene and aberrant expression is associated with numerous cancers and is associated with resistance to certain chemotherapies. A pseudogene of this gene is found on chromosome X. Read-through transcription also exists between this gene and the upstream COMM domain containing 3 (COMMD3) gene.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry